Update on Safety of ESAs in Cancer-Induced Anemia

Journal of the National Comprehensive Cancer Network : JNCCN - United States
doi 10.6004/jnccn.2012.0065
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Harborside Press, LLC

Related search

PCN34 Cost Analysis of Anemia Treatment With Erythropoiesis-Stimulating Agents (ESAs) in Cancer Patients Receiving Chemotherapy in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Darbepoetin Alpha in the Treatment of Cancer Chemotherapy-Induced Anemia

Therapeutics and Clinical Risk Management
Chemical HealthPharmacologySafetyMedicineToxicologySafety ResearchPharmaceutics
2007English

2015 Clinical Trials Update in Sickle Cell Anemia

American Journal of Hematology
Hematology
2015English

Eribulin for the Treatment of Metastatic Breast Cancer: An Update on Its Safety and Efficacy

International Journal of Women's Health
GynecologyOncologyMidwiferyMaternityObstetrics
2015English

Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update

Journal of Oncology Practice
Health PolicyOncology
2019English

Safety of Statins: An Update

Therapeutic Advances in Drug Safety
Pharmacology
2012English

Cancer Treatment-Induced Changes in Renal Function in Patients With Tumors – Update on Current Knowledge

Klinicka Onkologie
Oncology
2018English

Molecular Diagnostic Update in Hereditary Hemolytic Anemia and Neonatal Hyperbilirubinemia

International Journal of Laboratory Hematology
BiochemistryMedicineClinical BiochemistryHematology
2019English

Aortic Stenosis and Anemia With an Update on Approaches to Managing Angiodysplasia in 2018

Cardiology Journal
MedicineCardiovascular MedicineCardiology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy